Correlation Between Dr Reddys and MannKind Corp

Can any of the company-specific risk be diversified away by investing in both Dr Reddys and MannKind Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and MannKind Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dr Reddys Laboratories and MannKind Corp, you can compare the effects of market volatilities on Dr Reddys and MannKind Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of MannKind Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and MannKind Corp.

Diversification Opportunities for Dr Reddys and MannKind Corp

-0.68

Correlation Coefficient

Dr Reddys  MannKind Corp

Excellent diversification

The 3 months correlation between RDY and MannKind is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and MannKind Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MannKind Corp and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with MannKind Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MannKind Corp has no effect on the direction of Dr Reddys i.e., Dr Reddys and MannKind Corp go up and down completely randomly.

Pair Corralation between Dr Reddys and MannKind Corp

Considering the 90-day investment horizon Dr Reddys Laboratories is expected to under-perform the MannKind Corp. But the stock apears to be less risky and, when comparing its historical volatility, Dr Reddys Laboratories is 1.18 times less risky than MannKind Corp. The stock trades about -0.14 of its potential returns per unit of risk. The MannKind Corp is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  702.00  in MannKind Corp on August 31, 2024 and sell it today you would lose (24.00) from holding MannKind Corp or give up 3.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Dr Reddys Laboratories  vs.  MannKind Corp

Dr Reddys Laboratories

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dr Reddys Laboratories has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

MannKind Corp

Risk-Adjusted Performance

8 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in MannKind Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady forward-looking signals, MannKind Corp may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Dr Reddys and MannKind Corp

The main advantage of trading using opposite Dr Reddys and MannKind Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, MannKind Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MannKind Corp will offset losses from the drop in MannKind Corp's long position.

The idea behind Dr Reddys Laboratories and MannKind Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.